{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:06:22Z","timestamp":1792623982027,"version":"4.5.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41380-025-03160-4","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T09:47:07Z","timestamp":1756979227000},"page":"559-575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between FDG- and TSPO-PET signals across human and animal studies investigating neurodegenerative conditions: a systematic review"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8387-3832","authenticated-orcid":false,"given":"Luiza S.","family":"Machado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Vidor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lav\u00ednia","family":"Perquim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Limberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1567-3374","authenticated-orcid":false,"given":"Andr\u00e9ia","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2338-4495","authenticated-orcid":false,"given":"Carolina","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrine","family":"Rahmouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9777-0559","authenticated-orcid":false,"given":"Wagner","family":"S. Brum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Bellaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2134-9829","authenticated-orcid":false,"given":"Pamela C. L.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9282-0601","authenticated-orcid":false,"given":"Wyllians V.","family":"Borelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaderson C.","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8923-9656","authenticated-orcid":false,"given":"Maura","family":"Malpetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tharick A.","family":"Pascoal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo O.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6551-2002","authenticated-orcid":false,"given":"Paul","family":"Edison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1890-4193","authenticated-orcid":false,"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3930-4354","authenticated-orcid":false,"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Benedet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Serrano-Pozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9116-1376","authenticated-orcid":false,"given":"Pedro","family":"Rosa-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5349-0053","authenticated-orcid":false,"given":"Eduardo R.","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"3160_CR1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.cpet.2014.07.005","volume":"9","author":"M Sch\u00f6ll","year":"2014","unstructured":"Sch\u00f6ll M, Dami\u00e1n A, Engler H. Fluorodeoxyglucose PET in neurology and psychiatry. PET Clin. 2014;9:371\u201390. https:\/\/doi.org\/10.1016\/j.cpet.2014.07.005. v","journal-title":"PET Clin"},{"key":"3160_CR2","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1007\/s00259-021-05368-2","volume":"48","author":"G Sambuceti","year":"2021","unstructured":"Sambuceti G, Cossu V, Bauckneht M, Morbelli S, Orengo A, Carta S, et al. 18F-fluoro-2-deoxy-d-glucose (FDG) uptake. What are we looking at? Eur J Nucl Med Mol Imaging. 2021;48:1278\u201386. https:\/\/doi.org\/10.1007\/s00259-021-05368-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3160_CR3","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","volume":"19","author":"G Ch\u00e9telat","year":"2020","unstructured":"Ch\u00e9telat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, et al. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer\u2019s disease and other dementias. Lancet Neurol. 2020;19:951\u201362. https:\/\/doi.org\/10.1016\/S1474-4422(20)30314-8","journal-title":"Lancet Neurol"},{"key":"3160_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.15274\/NRJ-2014-10002","volume":"27","author":"M Tripathi","year":"2014","unstructured":"Tripathi M, Tripathi M, Damle N, Kushwaha S, Jaimini A, D\u2019Souza MM, et al. Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET\/CT. Neuroradiol J. 2014;27:13\u201321. https:\/\/doi.org\/10.15274\/NRJ-2014-10002","journal-title":"Neuroradiol J"},{"key":"3160_CR5","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s00018-007-7056-4","volume":"64","author":"S Sestini","year":"2007","unstructured":"Sestini S. The neural basis of functional neuroimaging signal with positron and single-photon emission tomography. Cell Mol Life Sci. 2007;64:1778\u201384. https:\/\/doi.org\/10.1007\/s00018-007-7056-4","journal-title":"Cell Mol Life Sci"},{"key":"3160_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nn.4492","volume":"20","author":"ER Zimmer","year":"2017","unstructured":"Zimmer ER, Parent MJ, Souza DG, Leuzy A, Lecrux C, Kim HI, et al. 18F]FDG PET signal is driven by astroglial glutamate transport. Nat Neurosci. 2017;20:393\u20135. https:\/\/doi.org\/10.1038\/nn.4492","journal-title":"Nat Neurosci"},{"key":"3160_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abe5640","volume":"13","author":"X Xiang","year":"2021","unstructured":"Xiang X, Wind K, Wiedemann T, Blume T, Shi Y, Briel N, et al. Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases. Sci Transl Med. 2021;13:eabe5640. https:\/\/doi.org\/10.1126\/scitranslmed.abe5640","journal-title":"Sci Transl Med"},{"key":"3160_CR8","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s00259-022-05682-3","volume":"49","author":"A Rocha","year":"2022","unstructured":"Rocha A, Bellaver B, Souza DG, Schu G, Fontana IC, Venturin GT, et al. Clozapine induces astrocyte-dependent FDG-PET hypometabolism. Eur J Nucl Med Mol Imaging. 2022;49:2251\u201364. https:\/\/doi.org\/10.1007\/s00259-022-05682-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3160_CR9","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1073\/pnas.74.9.3805","volume":"74","author":"C Braestrup","year":"1977","unstructured":"Braestrup C, Squires RF. Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc Natl Acad Sci USA. 1977;74:3805\u20139. https:\/\/doi.org\/10.1073\/pnas.74.9.3805","journal-title":"Proc Natl Acad Sci USA"},{"key":"3160_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2010.06.013","volume":"327","author":"A Batarseh","year":"2010","unstructured":"Batarseh A, Papadopoulos V. Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states. Mol Cell Endocrinol. 2010;327:1\u201312. https:\/\/doi.org\/10.1016\/j.mce.2010.06.013","journal-title":"Mol Cell Endocrinol"},{"key":"3160_CR11","doi-asserted-by":"publisher","first-page":"10809","DOI":"10.1523\/JNEUROSCI.1487-12.2012","volume":"32","author":"S Lavisse","year":"2012","unstructured":"Lavisse S, Guillermier M, H\u00e9rard AS, Petit F, Delahaye M, Van Camp N, et al. Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J Neurosci. 2012;32:10809\u201318. https:\/\/doi.org\/10.1523\/JNEUROSCI.1487-12.2012","journal-title":"J Neurosci"},{"key":"3160_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.108048","volume":"234","author":"TR Guilarte","year":"2022","unstructured":"Guilarte TR, Rodichkin AN, McGlothan JL, Acanda De La Rocha AM, Azzam DJ. Imaging neuroinflammation with TSPO: a new perspective on the cellular sources and subcellular localization. Pharmacol Ther. 2022;234:108048. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108048","journal-title":"Pharmacol Ther"},{"key":"3160_CR13","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3389\/fphar.2020.00986","volume":"11","author":"R Yao","year":"2020","unstructured":"Yao R, Pan R, Shang C, Li X, Cheng J, Xu J, et al. Translocator protein 18 kDa (TSPO) deficiency inhibits microglial activation and impairs mitochondrial function. Front Pharmacol. 2020;11:986. https:\/\/doi.org\/10.3389\/fphar.2020.00986","journal-title":"Front Pharmacol"},{"key":"3160_CR14","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.tips.2006.06.005","volume":"27","author":"V Papadopoulos","year":"2006","unstructured":"Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacap\u00e8re JJ, Lindemann P, et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006;27:402\u20139. https:\/\/doi.org\/10.1016\/j.tips.2006.06.005","journal-title":"Trends Pharmacol Sci"},{"key":"3160_CR15","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s00415-017-8565-1","volume":"264","author":"AA Crawshaw","year":"2017","unstructured":"Crawshaw AA, Robertson NP. The role of TSPO PET in assessing neuroinflammation. J Neurol. 2017;264:1825\u20137. https:\/\/doi.org\/10.1007\/s00415-017-8565-1","journal-title":"J Neurol"},{"key":"3160_CR16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3389\/fneur.2018.00625","volume":"9","author":"P Edison","year":"2018","unstructured":"Edison P, Donat CK, Sastre M. in vivo imaging of glial activation in Alzheimer\u2019s disease. Front Neurol. 2018;9:625. https:\/\/doi.org\/10.3389\/fneur.2018.00625","journal-title":"Front Neurol"},{"key":"3160_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/jnnp-2015-311336","volume":"87","author":"J Stefaniak","year":"2016","unstructured":"Stefaniak J, O\u2019Brien J. Imaging of neuroinflammation in dementia: a review. J Neurol Neurosurg Psychiatry. 2016;87:21\u20138. https:\/\/doi.org\/10.1136\/jnnp-2015-311336","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3160_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1001\/jamapsychiatry.2014.2427","volume":"72","author":"E Setiawan","year":"2015","unstructured":"Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G, et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry. 2015;72:268\u201375. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.2427","journal-title":"JAMA Psychiatry"},{"key":"3160_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2967\/jnumed.114.141713","volume":"57","author":"L Vivash","year":"2016","unstructured":"Vivash L, O\u2019Brien TJ. Imaging microglial activation with TSPO PET: lighting up neurologic diseases? J Nucl Med. 2016;57:165\u20138. https:\/\/doi.org\/10.2967\/jnumed.114.141713","journal-title":"J Nucl Med"},{"key":"3160_CR20","doi-asserted-by":"publisher","first-page":"e1989","DOI":"10.1212\/WNL.0000000000005610","volume":"90","author":"L Passamonti","year":"2018","unstructured":"Passamonti L, Rodr\u00edguez PV, Hong YT, Allinson KSJ, Bevan-Jones WR, Williamson D, et al. 11C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy. Neurology. 2018;90:e1989\u201396. https:\/\/doi.org\/10.1212\/WNL.0000000000005610","journal-title":"Neurology"},{"key":"3160_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.parkreldis.2020.11.011","volume":"82","author":"S Lavisse","year":"2021","unstructured":"Lavisse S, Goutal S, Wimberley C, Tonietto M, Bottlaender M, Gervais P, et al. Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging. Parkinsonism Relat Disord. 2021;82:29\u201336. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.11.011","journal-title":"Parkinsonism Relat Disord"},{"key":"3160_CR22","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3233\/JAD-150827","volume":"51","author":"GD Femminella","year":"2016","unstructured":"Femminella GD, Ninan S, Atkinson R, Fan Z, Brooks DJ, Edison P. Does microglial activation influence hippocampal volume and neuronal function in Alzheimer\u2019s disease and Parkinson\u2019s disease dementia? J Alzheimers Dis. 2016;51:1275\u201389. https:\/\/doi.org\/10.3233\/JAD-150827","journal-title":"J Alzheimers Dis"},{"key":"3160_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bbi.2023.07.023","volume":"113","author":"LJ De Picker","year":"2023","unstructured":"De Picker LJ, Morrens M, Branchi I, Haarman BCM, Terada T, Kang MS, et al. TSPO PET brain inflammation imaging: a transdiagnostic systematic review and meta-analysis of 156 case-control studies. Brain Behav Immun. 2023;113:415\u201331. https:\/\/doi.org\/10.1016\/j.bbi.2023.07.023","journal-title":"Brain Behav Immun"},{"key":"3160_CR24","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/brain\/awad322","volume":"147","author":"A Kouli","year":"2023","unstructured":"Kouli A, Spindler LRB, Fryer TD, Hong YT, Malpetti M, Aigbirhio FI, et al. Neuroinflammation is linked to dementia risk in Parkinson\u2019s disease. Brain. 2023;147:923\u201335. https:\/\/doi.org\/10.1093\/brain\/awad322","journal-title":"Brain"},{"key":"3160_CR25","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1093\/brain\/awad078","volume":"146","author":"M Malpetti","year":"2023","unstructured":"Malpetti M, Cope TE, Street D, Jones PS, Hezemans FH, Mak E, et al. Microglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementia. Brain. 2023;146:3221\u201331. https:\/\/doi.org\/10.1093\/brain\/awad078","journal-title":"Brain"},{"key":"3160_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/jnnp-2020-323698","volume":"92","author":"M Malpetti","year":"2021","unstructured":"Malpetti M, Rittman T, Jones PS, Cope TE, Passamonti L, Bevan-Jones WR, et al. In vivo PET imaging of neuroinflammation in familial frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2021;92:319\u201322. https:\/\/doi.org\/10.1136\/jnnp-2020-323698","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3160_CR27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1365-2990.2008.01006.x","volume":"35","author":"M Cosenza-Nashat","year":"2009","unstructured":"Cosenza-Nashat M, Zhao ML, Suh HS, Morgan J, Natividad R, Morgello S, et al. Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol Appl Neurobiol. 2009;35:306\u201328. https:\/\/doi.org\/10.1111\/j.1365-2990.2008.01006.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3160_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02383-4","volume":"19","author":"C Mu\u00f1oz-Castro","year":"2022","unstructured":"Mu\u00f1oz-Castro C, Noori A, Magdamo CG, Li Z, Marks JD, Frosch MP, et al. Cyclic multiplex fluorescent immunohistochemistry and machine learning reveal distinct states of astrocytes and microglia in normal aging and Alzheimer\u2019s disease. J Neuroinflammation. 2022;19:30. https:\/\/doi.org\/10.1186\/s12974-022-02383-4","journal-title":"J Neuroinflammation"},{"key":"3160_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02869-9","volume":"20","author":"EF Garland","year":"2023","unstructured":"Garland EF, Dennett O, Lau LC, Chatelet DS, Bottlaender M, Nicoll JAR, et al. The mitochondrial protein TSPO in Alzheimer\u2019s disease: relation to the severity of AD pathology and the neuroinflammatory environment. J Neuroinflammation. 2023;20:186 https:\/\/doi.org\/10.1186\/s12974-023-02869-9","journal-title":"J Neuroinflammation"},{"key":"3160_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/bpa.12763","volume":"30","author":"Y Gui","year":"2020","unstructured":"Gui Y, Marks JD, Das S, Hyman BT, Serrano-Pozo A. Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer\u2019s disease brains. Brain Pathol. 2020;30:151\u201364. https:\/\/doi.org\/10.1111\/bpa.12763","journal-title":"Brain Pathol"},{"key":"3160_CR31","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1093\/brain\/awz287","volume":"142","author":"E Nutma","year":"2019","unstructured":"Nutma E, Stephenson JA, Gorter RP, de Bruin J, Boucherie DM, Donat CK, et al. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis. Brain. 2019;142:3440\u201355. https:\/\/doi.org\/10.1093\/brain\/awz287","journal-title":"Brain"},{"key":"3160_CR32","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1002\/glia.24052","volume":"69","author":"E Nutma","year":"2021","unstructured":"Nutma E, Gebro E, Marzin MC, van der Valk P, Matthews PM, Owen DR, et al. Activated microglia do not increase 18\u2009kDa translocator protein (TSPO) expression in the multiple sclerosis brain. Glia. 2021;69:2447\u201358. https:\/\/doi.org\/10.1002\/glia.24052","journal-title":"Glia"},{"key":"3160_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40937-z","volume":"14","author":"E Nutma","year":"2023","unstructured":"Nutma E, Fancy N, Weinert M, Tsartsalis S, Marzin MC, Muirhead RCJ, et al. Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases. Nat Commun. 2023;14:5247. https:\/\/doi.org\/10.1038\/s41467-023-40937-z","journal-title":"Nat Commun"},{"key":"3160_CR34","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1177\/0271678X17710182","volume":"37","author":"DR Owen","year":"2017","unstructured":"Owen DR, Narayan N, Wells L, Healy L, Smyth E, Rabiner EA, et al. Pro-inflammatory activation of primary microglia and macrophages increases 18\u2009kDa translocator protein expression in rodents but not humans. J Cereb Blood Flow Metab. 2017;37:2679\u201390. https:\/\/doi.org\/10.1177\/0271678X17710182","journal-title":"J Cereb Blood Flow Metab"},{"key":"3160_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-023-01041-x","volume":"16","author":"K Ceyz\u00e9riat","year":"2023","unstructured":"Ceyz\u00e9riat K, Nicolaides A, Amoss\u00e9 Q, Fossey C, Cailly T, Fabis F, et al. Reactive astrocytes mediate TSPO overexpression in response to sustained CNTF exposure in the rat striatum. Mol Brain. 2023;16:57. https:\/\/doi.org\/10.1186\/s13041-023-01041-x","journal-title":"Mol Brain"},{"key":"3160_CR36","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3233\/JAD-200136","volume":"77","author":"BB Tournier","year":"2020","unstructured":"Tournier BB, Tsartsalis S, Ceyz\u00e9riat K, Fraser BH, Gr\u00e9goire MC, K\u00f6vari E, et al. Astrocytic TSPO upregulation appears before microglial TSPO in Alzheimer\u2019s disease. J Alzheimers Dis. 2020;77:1043\u201356. https:\/\/doi.org\/10.3233\/JAD-200136","journal-title":"J Alzheimers Dis"},{"key":"3160_CR37","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71 https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"3160_CR38","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. https:\/\/doi.org\/10.1136\/bmj.n160","journal-title":"BMJ"},{"key":"3160_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5:210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"3160_CR40","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1161\/01.STR.0000125719.25853.20","volume":"35","author":"MR Macleod","year":"2004","unstructured":"Macleod MR, O\u2019Collins T, Howells DW, Donnan GA. Pooling of animal experimental data reveals influence of study design and publication bias. Stroke. 2004;35:1203\u20138. https:\/\/doi.org\/10.1161\/01.STR.0000125719.25853.20","journal-title":"Stroke"},{"key":"3160_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43. https:\/\/doi.org\/10.1186\/1471-2288-14-43","journal-title":"BMC Med Res Methodol"},{"key":"3160_CR42","unstructured":"Critical Appraisal Tools | JBI. https:\/\/jbi.global\/critical-appraisal-tools"},{"key":"3160_CR43","doi-asserted-by":"publisher","first-page":"954","DOI":"10.2967\/jnumed.115.167858","volume":"57","author":"M Brendel","year":"2016","unstructured":"Brendel M, Probst F, Jaworska A, Overhoff F, Korzhova V, Albert NL, et al. Glial activation and glucose metabolism in a transgenic amyloid mouse model: a triple-tracer PET study. J Nucl Med. 2016;57:954\u201360. https:\/\/doi.org\/10.2967\/jnumed.115.167858","journal-title":"J Nucl Med"},{"key":"3160_CR44","doi-asserted-by":"publisher","first-page":"103484","DOI":"10.1016\/j.nicl.2023.103484","volume":"39","author":"L Vogler","year":"2023","unstructured":"Vogler L, Ballweg A, Bohr B, Briel N, Wind K, Antons M, et al. Assessment of synaptic loss in mouse models of \u03b2-amyloid and tau pathology using [18F]UCB-H PET imaging. Neuroimage Clin. 2023;39:103484. https:\/\/doi.org\/10.1016\/j.nicl.2023.103484","journal-title":"Neuroimage Clin"},{"key":"3160_CR45","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1177\/0271678X16677990","volume":"37","author":"JS Takkinen","year":"2017","unstructured":"Takkinen JS, L\u00f3pez-Pic\u00f3n FR, Al Majidi R, Eskola O, Krzyczmonik A, Keller TR, et al. Brain energy metabolism and neuroinflammation in ageing APP\/PS1-21 mice using longitudinal 18F-FDG and 18F-DPA-714 PET imaging. J Cereb Blood Flow Metab. 2017;37:2870\u201382. https:\/\/doi.org\/10.1177\/0271678X16677990","journal-title":"J Cereb Blood Flow Metab"},{"key":"3160_CR46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.neurobiolaging.2012.04.016","volume":"34","author":"S Rapic","year":"2013","unstructured":"Rapic S, Backes H, Viel T, Kummer MP, Monfared P, Neumaier B, et al. Imaging microglial activation and glucose consumption in a mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2013;34:351\u20134. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.04.016","journal-title":"Neurobiol Aging"},{"key":"3160_CR47","doi-asserted-by":"publisher","first-page":"8387","DOI":"10.1007\/s12035-024-04106-7","volume":"61","author":"Y Kong","year":"2024","unstructured":"Kong Y, Maschio CA, Shi X, Xie F, Zuo C, Konietzko U, et al. Relationship between reactive astrocytes, by [18F]SMBT-1 imaging, with Amyloid-beta, tau, glucose metabolism, and TSPO in mouse models of Alzheimer\u2019s disease. Mol Neurobiol. 2024;61:8387\u2013401. https:\/\/doi.org\/10.1007\/s12035-024-04106-7","journal-title":"Mol Neurobiol"},{"key":"3160_CR48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13024-022-00547-7","volume":"17","author":"D Xia","year":"2022","unstructured":"Xia D, Lianoglou S, Sandmann T, Calvert M, Suh JH, Thomsen E, et al. Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia. Mol Neurodegener. 2022;17:41 https:\/\/doi.org\/10.1186\/s13024-022-00547-7","journal-title":"Mol Neurodegener"},{"key":"3160_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.134938","volume":"728","author":"Y Liu","year":"2020","unstructured":"Liu Y, Xu Y, Li M, Pan D, Li Y, Wang Y, et al. Multi-target PET evaluation in APP\/PS1\/tau mouse model of Alzheimer\u2019s disease. Neurosci Lett. 2020;728:134938. https:\/\/doi.org\/10.1016\/j.neulet.2020.134938","journal-title":"Neurosci Lett"},{"key":"3160_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2024.123079","volume":"462","author":"Y Kong","year":"2024","unstructured":"Kong Y, Cao L, Wang J, Zhuang J, Xie F, Zuo C, et al. In vivo reactive astrocyte imaging using [18F]SMBT-1 in tauopathy and familial Alzheimer\u2019s disease mouse models: a multi-tracer study. J Neurol Sci. 2024;462:123079. https:\/\/doi.org\/10.1016\/j.jns.2024.123079","journal-title":"J Neurol Sci"},{"key":"3160_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03080-0","volume":"21","author":"M Poxleitner","year":"2024","unstructured":"Poxleitner M, Hoffmann SHL, Berezhnoy G, Ionescu TM, Gonzalez-Menendez I, Maier FC, et al. Western diet increases brain metabolism and adaptive immune responses in a mouse model of amyloidosis. J Neuroinflammation. 2024;21:129. https:\/\/doi.org\/10.1186\/s12974-024-03080-0","journal-title":"J Neuroinflammation"},{"key":"3160_CR52","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1007\/s12035-022-02793-8","volume":"59","author":"H Endepols","year":"2022","unstructured":"Endepols H, Anglada-Huguet M, Mandelkow E, Schmidt Y, Krapf P, Zlatopolskiy BD, et al. Assessment of the in vivo relationship between cerebral hypometabolism, tau deposition, TSPO expression, and synaptic density in a tauopathy mouse model: a multi-tracer PET study. Mol Neurobiol. 2022;59:3402\u201313. https:\/\/doi.org\/10.1007\/s12035-022-02793-8","journal-title":"Mol Neurobiol"},{"key":"3160_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01883-5","volume":"17","author":"F Eckenweber","year":"2020","unstructured":"Eckenweber F, Medina-Luque J, Blume T, Sacher C, Biechele G, Wind K, et al. Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning. J Neuroinflammation. 2020;17:208. https:\/\/doi.org\/10.1186\/s12974-020-01883-5","journal-title":"J Neuroinflammation"},{"key":"3160_CR54","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.15252\/embj.201796516","volume":"36","author":"G Kleinberger","year":"2017","unstructured":"Kleinberger G, Brendel M, Mracsko E, Wefers B, Groeneweg L, Xiang X, et al. The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism. EMBO J. 2017;36:1837\u201353. https:\/\/doi.org\/10.15252\/embj.201796516","journal-title":"EMBO J"},{"key":"3160_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0700-x","volume":"13","author":"AM Barron","year":"2016","unstructured":"Barron AM, Tokunaga M, Zhang MR, Ji B, Suhara T, Higuchi M. Assessment of neuroinflammation in a mouse model of obesity and \u03b2-amyloidosis using PET. J Neuroinflammation. 2016;13:221. https:\/\/doi.org\/10.1186\/s12974-016-0700-x","journal-title":"J Neuroinflammation"},{"key":"3160_CR56","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1021\/acschemneuro.3c00202","volume":"14","author":"P Ye","year":"2023","unstructured":"Ye P, Bi L, Yang M, Qiu Y, Huang G, Liu Y, et al. Activated microglia in the early stage of a rat model of Parkinson\u2019s disease: revealed by PET-MRI imaging by [18F]DPA-714 targeting TSPO. ACS Chem Neurosci. 2023;14:2183\u201392. https:\/\/doi.org\/10.1021\/acschemneuro.3c00202","journal-title":"ACS Chem Neurosci"},{"key":"3160_CR57","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1093\/brain\/awv288","volume":"138","author":"Z Fan","year":"2015","unstructured":"Fan Z, Okello AA, Brooks DJ, Edison P. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer\u2019s disease. Brain. 2015;138:3685\u201398. https:\/\/doi.org\/10.1093\/brain\/awv288","journal-title":"Brain"},{"key":"3160_CR58","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jalz.2014.06.016","volume":"11","author":"Z Fan","year":"2015","unstructured":"Fan Z, Aman Y, Ahmed I, Chetelat G, Landeau B, Ray Chaudhuri K, et al. Influence of microglial activation on neuronal function in Alzheimer\u2019s and Parkinson\u2019s disease dementia. Alzheimers Dement. 2015;11:608\u201321.e7. https:\/\/doi.org\/10.1016\/j.jalz.2014.06.016","journal-title":"Alzheimers Dement"},{"key":"3160_CR59","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00259-010-1612-0","volume":"38","author":"M Yokokura","year":"2011","unstructured":"Yokokura M, Mori N, Yagi S, Yoshikawa E, Kikuchi M, Yoshihara Y, et al. In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2011;38:343\u201351. https:\/\/doi.org\/10.1007\/s00259-010-1612-0","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3160_CR60","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13195-020-00619-0","volume":"12","author":"G Tondo","year":"2020","unstructured":"Tondo G, Iaccarino L, Caminiti SP, Presotto L, Santangelo R, Iannaccone S, et al. The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer\u2019s disease. Alzheimers Res Ther. 2020;12:50. https:\/\/doi.org\/10.1186\/s13195-020-00619-0","journal-title":"Alzheimers Res Ther"},{"key":"3160_CR61","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/npp.2012.255","volume":"38","author":"P Edison","year":"2013","unstructured":"Edison P, Ahmed I, Fan Z, Hinz R, Gelosa G, Ray Chaudhuri K, et al. Microglia, amyloid, and glucose metabolism in Parkinson\u2019s disease with and without dementia. Neuropsychopharmacology. 2013;38:938\u201349. https:\/\/doi.org\/10.1038\/npp.2012.255","journal-title":"Neuropsychopharmacology"},{"key":"3160_CR62","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/acn3.50802","volume":"6","author":"MJ Kim","year":"2019","unstructured":"Kim MJ, McGwier M, Jenko KJ, Snow J, Morse C, Zoghbi SS, et al. Neuroinflammation in frontotemporal lobar degeneration revealed by 11 C-PBR28 PET. Ann Clin Transl Neurol. 2019;6:1327\u201331. https:\/\/doi.org\/10.1002\/acn3.50802","journal-title":"Ann Clin Transl Neurol"},{"key":"3160_CR63","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41380-019-0609-8","volume":"25","author":"YL Tan","year":"2020","unstructured":"Tan YL, Yuan Y, Tian L. Microglial regional heterogeneity and its role in the brain. Mol Psychiatry. 2020;25:351\u201367. https:\/\/doi.org\/10.1038\/s41380-019-0609-8","journal-title":"Mol Psychiatry"},{"key":"3160_CR64","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/alz.12389","volume":"18","author":"D Boche","year":"2022","unstructured":"Boche D, Gordon MN. Diversity of transcriptomic microglial phenotypes in aging and Alzheimer\u2019s disease. Alzheimers Dement. 2022;18:360\u201376. https:\/\/doi.org\/10.1002\/alz.12389","journal-title":"Alzheimers Dement"},{"key":"3160_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19737-2","volume":"11","author":"M Olah","year":"2020","unstructured":"Olah M, Menon V, Habib N, Taga MF, Ma Y, Yung CJ, et al. Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer\u2019s disease. Nat Commun. 2020;11:6129. https:\/\/doi.org\/10.1038\/s41467-020-19737-2","journal-title":"Nat Commun"},{"key":"3160_CR66","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cmet.2023.03.006","volume":"35","author":"P Hasel","year":"2023","unstructured":"Hasel P, Aisenberg WH, Bennett FC, Liddelow SA. Molecular and metabolic heterogeneity of astrocytes and microglia. Cell Metab. 2023;35:555\u201370. https:\/\/doi.org\/10.1016\/j.cmet.2023.03.006","journal-title":"Cell Metab"},{"key":"3160_CR67","doi-asserted-by":"publisher","unstructured":"Fontana IC, Ferreira PCL, Miron D, Santos LE, Ferreira ST, Souza DO, et al. Rapid size-exclusion high performance liquid chromatography method for the quality control of amyloid-\u03b2 oligomers. J Chromatogr A. 2021;1643:462024. https:\/\/doi.org\/10.1016\/j.chroma.2021.462024","DOI":"10.1016\/j.chroma.2021.462024"},{"key":"3160_CR68","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1002\/glia.23271","volume":"66","author":"S Ghosh","year":"2018","unstructured":"Ghosh S, Castillo E, Frias ES, Swanson RA. Bioenergetic regulation of microglia. Glia. 2018;66:1200\u201312. https:\/\/doi.org\/10.1002\/glia.23271","journal-title":"Glia"},{"key":"3160_CR69","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13024-019-0305-9","volume":"14","author":"L Wang","year":"2019","unstructured":"Wang L, Pavlou S, Du X, Bhuckory M, Xu H, Chen M. Glucose transporter 1 critically controls microglial activation through facilitating glycolysis. Mol Neurodegener. 2019;14:2. https:\/\/doi.org\/10.1186\/s13024-019-0305-9","journal-title":"Mol Neurodegener"},{"key":"3160_CR70","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00401-021-02263-w","volume":"141","author":"E Gerrits","year":"2021","unstructured":"Gerrits E, Brouwer N, Kooistra SM, Woodbury ME, Vermeiren Y, Lambourne M, et al. Distinct amyloid-\u03b2 and tau-associated microglia profiles in Alzheimer\u2019s disease. Acta Neuropathol. 2021;141:681\u201396. https:\/\/doi.org\/10.1007\/s00401-021-02263-w","journal-title":"Acta Neuropathol"},{"key":"3160_CR71","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s40478-020-01047-9","volume":"8","author":"MEV Swanson","year":"2020","unstructured":"Swanson MEV, Scotter EL, Smyth LCD, Murray HC, Ryan B, Turner C, et al. Identification of a dysfunctional microglial population in human Alzheimer\u2019s disease cortex using novel single-cell histology image analysis. Acta Neuropathol Commun. 2020;8:170. https:\/\/doi.org\/10.1186\/s40478-020-01047-9","journal-title":"Acta Neuropathol Commun"},{"key":"3160_CR72","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1126\/science.1113694","volume":"309","author":"K Santacruz","year":"2005","unstructured":"Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science. 2005;309:476\u201381. https:\/\/doi.org\/10.1126\/science.1113694","journal-title":"Science"},{"key":"3160_CR73","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.15252\/embj.201797397","volume":"36","author":"H Sasaguri","year":"2017","unstructured":"Sasaguri H, Nilsson P, Hashimoto S, Nagata K, Saito T, De Strooper B, et al. APP mouse models for Alzheimer\u2019s disease preclinical studies. EMBO J. 2017;36:2473\u201387. https:\/\/doi.org\/10.15252\/embj.201797397","journal-title":"EMBO J"},{"key":"3160_CR74","doi-asserted-by":"publisher","first-page":"eabc8098","DOI":"10.1126\/sciadv.abc8098","volume":"6","author":"CW Fung","year":"2020","unstructured":"Fung CW, Guo J, Fu H, Figueroa HY, Konofagou EE, Duff KE. Atrophy associated with tau pathology precedes overt cell death in a mouse model of progressive tauopathy. Sci Adv. 2020;6:eabc8098. https:\/\/doi.org\/10.1126\/sciadv.abc8098","journal-title":"Sci Adv"},{"key":"3160_CR75","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito T, Matsuba Y, Mihira N, Takano J, Nilsson P, Itohara S, et al. Single App knock-in mouse models of Alzheimer\u2019s disease. Nat Neurosci. 2014;17:661\u20133. https:\/\/doi.org\/10.1038\/nn.3697","journal-title":"Nat Neurosci"},{"key":"3160_CR76","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/sj.embor.7400784","volume":"7","author":"R Radde","year":"2006","unstructured":"Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, Stoltze L, et al. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep. 2006;7:940\u20136. https:\/\/doi.org\/10.1038\/sj.embor.7400784","journal-title":"EMBO Rep"},{"key":"3160_CR77","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000170884","volume":"6","author":"L Ozmen","year":"2009","unstructured":"Ozmen L, Albientz A, Czech C, Jacobsen H. Expression of transgenic APP mRNA is the key determinant for beta-amyloid deposition in PS2APP transgenic mice. Neurodegener Dis. 2009;6:29\u201336. https:\/\/doi.org\/10.1159\/000170884","journal-title":"Neurodegener Dis"},{"key":"3160_CR78","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/mrm.21985","volume":"62","author":"C Weidensteiner","year":"2009","unstructured":"Weidensteiner C, Metzger F, Bruns A, Bohrmann B, Kuennecke B, von Kienlin M. Cortical hypoperfusion in the B6.PS2APP mouse model for Alzheimer\u2019s disease: comprehensive phenotyping of vascular and tissular parameters by MRI. Magn Reson Med. 2009;62:35\u201345. https:\/\/doi.org\/10.1002\/mrm.21985","journal-title":"Magn Reson Med"},{"key":"3160_CR79","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/s0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003;39:409\u201321. https:\/\/doi.org\/10.1016\/s0896-6273(03)00434-3","journal-title":"Neuron"},{"key":"3160_CR80","doi-asserted-by":"publisher","first-page":"10637","DOI":"10.1523\/JNEUROSCI.3279-05.2005","volume":"25","author":"M Ramsden","year":"2005","unstructured":"Ramsden M, Kotilinek L, Forster C, Paulson J, McGowan E, SantaCruz K, et al. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J Neurosci. 2005;25:10637\u201347. https:\/\/doi.org\/10.1523\/JNEUROSCI.3279-05.2005","journal-title":"J Neurosci"},{"key":"3160_CR81","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13024-023-00601-y","volume":"18","author":"K Wenger","year":"2023","unstructured":"Wenger K, Viode A, Schlaffner CN, van Zalm P, Cheng L, Dellovade T, et al. Common mouse models of tauopathy reflect early but not late human disease. Mol Neurodegener. 2023;18:10. https:\/\/doi.org\/10.1186\/s13024-023-00601-y","journal-title":"Mol Neurodegener"},{"key":"3160_CR82","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC, et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron. 2007;53:337\u201351. https:\/\/doi.org\/10.1016\/j.neuron.2007.01.010. [published correction appears in Neuron. 2007 Apr 19;54(2):343-4]","journal-title":"Neuron"},{"key":"3160_CR83","doi-asserted-by":"publisher","first-page":"E4376","DOI":"10.1073\/pnas.1411649111","volume":"111","author":"BB Holmes","year":"2014","unstructured":"Holmes BB, Furman JL, Mahan TE, Yamasaki TR, Mirbaha H, Eades WC, et al. Proteopathic tau seeding predicts tauopathy in vivo. Proc Natl Acad Sci USA. 2014;111:E4376\u201385. https:\/\/doi.org\/10.1073\/pnas.1411649111","journal-title":"Proc Natl Acad Sci USA"},{"key":"3160_CR84","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1126\/science.1248725","volume":"343","author":"L Jaremko","year":"2014","unstructured":"Jaremko L, Jaremko M, Giller K, Becker S, Zweckstetter M. Structure of the mitochondrial translocator protein in complex with a diagnostic ligand. Science. 2014;343:1363\u20136. https:\/\/doi.org\/10.1126\/science.1248725","journal-title":"Science"},{"key":"3160_CR85","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1126\/science.aaa1534","volume":"347","author":"Y Guo","year":"2015","unstructured":"Guo Y, Kalathur RC, Liu Q, Kloss B, Bruni R, Ginter C, et al. Protein structure. Structure and activity of tryptophan-rich TSPO proteins. Science. 2015;347:551\u20135. https:\/\/doi.org\/10.1126\/science.aaa1534","journal-title":"Science"},{"key":"3160_CR86","doi-asserted-by":"publisher","first-page":"16555","DOI":"10.1002\/chem.201502314","volume":"21","author":"Jaremko \u0141","year":"2015","unstructured":"Jaremko \u0141, Jaremko M, Giller K, Becker S, Zweckstetter M. Conformational flexibility in the transmembrane protein TSPO. Chemistry. 2015;21:16555\u201363. https:\/\/doi.org\/10.1002\/chem.201502314","journal-title":"Chemistry"},{"key":"3160_CR87","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1021\/acs.biochem.2c00612","volume":"62","author":"J Liu","year":"2023","unstructured":"Liu J, Hiser C, Li F, Hall R, Garavito RM, Ferguson-Miller S. New TSPO crystal structures of mutant and heme-bound forms with altered flexibility, ligand binding, and porphyrin degradation activity. Biochemistry. 2023;62:1262\u201373. https:\/\/doi.org\/10.1021\/acs.biochem.2c00612. [published correction appears in Biochemistry. 2023 Jun 6;62(11):1832]","journal-title":"Biochemistry"},{"key":"3160_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.2011.147","volume":"32","author":"DR Owen","year":"2012","unstructured":"Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, et al. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab. 2012;32:1\u20135. https:\/\/doi.org\/10.1038\/jcbfm.2011.147","journal-title":"J Cereb Blood Flow Metab"},{"key":"3160_CR89","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson 3rd","year":"2023","unstructured":"Wilson DM 3rd, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I. Hallmarks of neurodegenerative diseases. Cell. 2023;186:693\u2013714. https:\/\/doi.org\/10.1016\/j.cell.2022.12.032","journal-title":"Cell"},{"key":"3160_CR90","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/s41593-018-0221-2","volume":"21","author":"H Fu","year":"2018","unstructured":"Fu H, Hardy J, Duff KE. Selective vulnerability in neurodegenerative diseases. Nat Neurosci. 2018;21:1350\u20138. https:\/\/doi.org\/10.1038\/s41593-018-0221-2","journal-title":"Nat Neurosci"},{"key":"3160_CR91","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1126\/science.aay0198","volume":"365","author":"B Zott","year":"2019","unstructured":"Zott B, Simon MM, Hong W, Unger F, Chen-Engerer HJ, Frosch MP, et al. A vicious cycle of \u03b2 amyloid-dependent neuronal hyperactivation. Science. 2019;365:559\u201365. https:\/\/doi.org\/10.1126\/science.aay0198","journal-title":"Science"},{"key":"3160_CR92","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 2024;20:5143\u201369. https:\/\/doi.org\/10.1002\/alz.13859","journal-title":"Alzheimers Dement"},{"key":"3160_CR93","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/brain\/awy059","volume":"141","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Wiste HJ, Schwarz CG, Lowe VJ, Senjem ML, Vemuri P, et al. Longitudinal tau PET in ageing and Alzheimer\u2019s disease. Brain. 2018;141:1517\u201328. https:\/\/doi.org\/10.1093\/brain\/awy059","journal-title":"Brain"},{"key":"3160_CR94","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.1002\/alz.13158","volume":"19","author":"A Bollack","year":"2023","unstructured":"Bollack A, Pemberton HG, Collij LE, Markiewicz P, Cash DM, Farrar G, et al. Longitudinal amyloid and tau PET imaging in Alzheimer\u2019s disease: A systematic review of methodologies and factors affecting quantification. Alzheimers Dement. 2023;19:5232\u201352. https:\/\/doi.org\/10.1002\/alz.13158","journal-title":"Alzheimers Dement"},{"key":"3160_CR95","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1093\/brain\/aws125","volume":"135","author":"N Villain","year":"2012","unstructured":"Villain N, Ch\u00e9telat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, et al. Regional dynamics of amyloid-\u03b2 deposition in healthy elderly, mild cognitive impairment and Alzheimer\u2019s disease: a voxelwise PiB-PET longitudinal study. Brain. 2012;135:2126\u201339. https:\/\/doi.org\/10.1093\/brain\/aws125","journal-title":"Brain"},{"key":"3160_CR96","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm6131","volume":"385","author":"PS Minhas","year":"2024","unstructured":"Minhas PS, Jones JR, Latif-Hernandez A, Sugiura Y, Durairaj AS, Wang Q, et al. Restoring hippocampal glucose metabolism rescues cognition across Alzheimer\u2019s disease pathologies. Science. 2024;385:eabm6131. https:\/\/doi.org\/10.1126\/science.abm6131","journal-title":"Science"},{"key":"3160_CR97","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1523\/JNEUROSCI.2339-19.2020","volume":"40","author":"SE Dos Santos","year":"2020","unstructured":"Dos Santos SE, Medeiros M, Porfirio J, Tavares W, Pess\u00f4a L, Grinberg L, et al. Similar microglial cell densities across brain structures and mammalian species: implications for brain tissue function. J Neurosci. 2020;40:4622\u201343. https:\/\/doi.org\/10.1523\/JNEUROSCI.2339-19.2020","journal-title":"J Neurosci"},{"key":"3160_CR98","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/cne.21974","volume":"513","author":"FA Azevedo","year":"2009","unstructured":"Azevedo FA, Carvalho LR, Grinberg LT, Farfel JM, Ferretti RE, Leite RE, et al. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J Comp Neurol. 2009;513:532\u201341. https:\/\/doi.org\/10.1002\/cne.21974","journal-title":"J Comp Neurol"},{"key":"3160_CR99","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/neuro.09.031.2009","volume":"3","author":"S Herculano-Houzel","year":"2009","unstructured":"Herculano-Houzel S. The human brain in numbers: a linearly scaled-up primate brain. Front Hum Neurosci. 2009;3:31. https:\/\/doi.org\/10.3389\/neuro.09.031.2009","journal-title":"Front Hum Neurosci"},{"key":"3160_CR100","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/glia.22683","volume":"62","author":"S Herculano-Houzel","year":"2014","unstructured":"Herculano-Houzel S. The glia\/neuron ratio: how it varies uniformly across brain structures and species and what that means for brain physiology and evolution. Glia. 2014;62:1377\u201391. https:\/\/doi.org\/10.1002\/glia.22683","journal-title":"Glia"},{"key":"3160_CR101","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481\u20137. https:\/\/doi.org\/10.1038\/nature21029","journal-title":"Nature"},{"key":"3160_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/srep16622","volume":"5","author":"LB Wood","year":"2015","unstructured":"Wood LB, Winslow AR, Proctor EA, McGuone D, Mordes DA, Frosch MP, et al. Identification of neurotoxic cytokines by profiling Alzheimer\u2019s disease tissues and neuron culture viability screening. Sci Rep. 2015;5:16622. https:\/\/doi.org\/10.1038\/srep16622","journal-title":"Sci Rep"},{"key":"3160_CR103","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11481-023-10059-w","volume":"18","author":"L Meyer-Arndt","year":"2023","unstructured":"Meyer-Arndt L, Kerkering J, Kuehl T, Infante AG, Paul F, Rosiewicz KS, et al. Inflammatory cytokines associated with multiple sclerosis directly induce alterations of neuronal cytoarchitecture in human neurons. J Neuroimmune Pharmacol. 2023;18:145\u201359. https:\/\/doi.org\/10.1007\/s11481-023-10059-w","journal-title":"J Neuroimmune Pharmacol"},{"key":"3160_CR104","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/glia.20671","volume":"56","author":"M Gavillet","year":"2008","unstructured":"Gavillet M, Allaman I, Magistretti PJ. Modulation of astrocytic metabolic phenotype by proinflammatory cytokines. Glia. 2008;56:975\u201389. https:\/\/doi.org\/10.1002\/glia.20671","journal-title":"Glia"},{"key":"3160_CR105","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3978\/j.issn.2305-5839.2015.03.49","volume":"3","author":"WY Wang","year":"2015","unstructured":"Wang WY, Tan MS, Yu JT, Tan L. Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann Transl Med. 2015;3:136. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2015.03.49","journal-title":"Ann Transl Med"},{"key":"3160_CR106","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/bs.irn.2020.03.017","volume":"154","author":"P Edison","year":"2020","unstructured":"Edison P. Neuroinflammation, microglial activation, and glucose metabolism in neurodegenerative diseases. Int Rev Neurobiol. 2020;154:325\u201344. https:\/\/doi.org\/10.1016\/bs.irn.2020.03.017","journal-title":"Int Rev Neurobiol"},{"key":"3160_CR107","doi-asserted-by":"publisher","first-page":"401","DOI":"10.14283\/jpad.2023.54","volume":"10","author":"A Bieger","year":"2023","unstructured":"Bieger A, Rocha A, Bellaver B, Machado L, Da Ros L, Borelli WV, et al. Neuroinflammation biomarkers in the AT(N) framework across the Alzheimer\u2019s disease continuum. J Prev Alzheimers Dis. 2023;10:401\u201317. https:\/\/doi.org\/10.14283\/jpad.2023.54","journal-title":"J Prev Alzheimers Dis"},{"key":"3160_CR108","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nn.4547","volume":"20","author":"TL Tay","year":"2017","unstructured":"Tay TL, Mai D, Dautzenberg J, Fern\u00e1ndez-Klett F, Lin G, Sagar, et al. A new fate mapping system reveals context-dependent random or clonal expansion of microglia. Nat Neurosci. 2017;20:793\u2013803. https:\/\/doi.org\/10.1038\/nn.4547","journal-title":"Nat Neurosci"},{"key":"3160_CR109","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169:1276\u201390.e17. https:\/\/doi.org\/10.1016\/j.cell.2017.05.018","journal-title":"Cell"},{"key":"3160_CR110","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","volume":"110","author":"RC Paolicelli","year":"2022","unstructured":"Paolicelli RC, Sierra A, Stevens B, Tremblay ME, Aguzzi A, Ajami B, et al. Microglia states and nomenclature: a field at its crossroads. Neuron. 2022;110:3458\u201383. https:\/\/doi.org\/10.1016\/j.neuron.2022.10.020","journal-title":"Neuron"},{"key":"3160_CR111","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17:157\u201372. https:\/\/doi.org\/10.1038\/s41582-020-00435-y","journal-title":"Nat Rev Neurol"},{"key":"3160_CR112","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s43587-022-00310-z","volume":"2","author":"JB Pereira","year":"2022","unstructured":"Pereira JB, Janelidze S, Strandberg O, Whelan CD, Zetterberg H, Blennow K, et al. Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer\u2019s disease pathology. Nat Aging. 2022;2:1138\u201344. https:\/\/doi.org\/10.1038\/s43587-022-00310-z","journal-title":"Nat Aging"},{"key":"3160_CR113","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade1474","volume":"9","author":"JP Ferrari-Souza","year":"2023","unstructured":"Ferrari-Souza JP, Lussier FZ, Leffa DT, Therriault J, Tissot C, Bellaver B, et al. APOE\u03b54 associates with microglial activation independently of A\u03b2 plaques and tau tangles. Sci Adv. 2023;9:eade1474. https:\/\/doi.org\/10.1126\/sciadv.ade1474","journal-title":"Sci Adv"},{"key":"3160_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02244-6","volume":"18","author":"H Choi","year":"2021","unstructured":"Choi H, Choi Y, Lee EJ, Kim H, Lee Y, Kwon S, et al. Hippocampal glucose uptake as a surrogate of metabolic change of microglia in Alzheimer\u2019s disease. J Neuroinflammation. 2021;18:190. https:\/\/doi.org\/10.1186\/s12974-021-02244-6","journal-title":"J Neuroinflammation"},{"key":"3160_CR115","doi-asserted-by":"publisher","DOI":"10.1002\/alz.067792","volume":"19","author":"H Crook","year":"2023","unstructured":"Crook H, Wahdan M, Edison P. The dynamic functional role of triggering receptor expressed on myeloid cells 2 (TREM2) assessed with cerebrospinal fluid and positron emission tomography measures. Alzheimer\u2019s Dement. 2023;19:e067792. https:\/\/doi.org\/10.1002\/alz.067792","journal-title":"Alzheimer\u2019s Dement"},{"key":"3160_CR116","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3390\/biomedicines11030725","volume":"11","author":"CG Bonomi","year":"2023","unstructured":"Bonomi CG, Chiaravalloti A, Camedda R, Ricci F, Mercuri NB, Schillaci O, et al. Functional correlates of microglial and astrocytic activity in symptomatic sporadic Alzheimer\u2019s disease: a CSF\/18F-FDG-PET study. Biomedicines. 2023;11:725. https:\/\/doi.org\/10.3390\/biomedicines11030725","journal-title":"Biomedicines"},{"key":"3160_CR117","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202216987","volume":"15","author":"D Biel","year":"2023","unstructured":"Biel D, Su\u00e1rez-Calvet M, Hager P, Rubinski A, Dewenter A, Steward A, et al. sTREM2 is associated with amyloid-related p-tau increases and glucose hypermetabolism in Alzheimer\u2019s disease. EMBO Mol Med. 2023;15:e16987. https:\/\/doi.org\/10.15252\/emmm.202216987","journal-title":"EMBO Mol Med"},{"key":"3160_CR118","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2967\/jnumed.110.087031","volume":"53","author":"SF Carter","year":"2012","unstructured":"Carter SF, Sch\u00f6ll M, Almkvist O, Wall A, Engler H, L\u00e5ngstr\u00f6m B, et al. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. J Nucl Med. 2012;53:37\u201346. https:\/\/doi.org\/10.2967\/jnumed.110.087031","journal-title":"J Nucl Med"},{"key":"3160_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/srep16404","volume":"5","author":"M Sch\u00f6ll","year":"2015","unstructured":"Sch\u00f6ll M, Carter SF, Westman E, Rodriguez-Vieitez E, Almkvist O, Thordardottir S, et al. Early astrocytosis in autosomal dominant Alzheimer\u2019s disease measured in vivo by multi-tracer positron emission tomography. Sci Rep. 2015;5:16404. https:\/\/doi.org\/10.1038\/srep16404","journal-title":"Sci Rep"},{"key":"3160_CR120","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s00259-018-4217-7","volume":"46","author":"SF Carter","year":"2019","unstructured":"Carter SF, Chiotis K, Nordberg A, Rodriguez-Vieitez E. Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2019;46:348\u201356. https:\/\/doi.org\/10.1007\/s00259-018-4217-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3160_CR121","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1038\/s41593-019-0525-x","volume":"22","author":"R Mancuso","year":"2019","unstructured":"Mancuso R, Van Den Daele J, Fattorelli N, Wolfs L, Balusu S, Burton O, et al. Stem-cell-derived human microglia transplanted in mouse brain to study human disease. Nat Neurosci. 2019;22:2111\u20136. https:\/\/doi.org\/10.1038\/s41593-019-0525-x","journal-title":"Nat Neurosci"},{"key":"3160_CR122","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.652748","volume":"9","author":"K Sharma","year":"2021","unstructured":"Sharma K, Bisht K, Eyo UB. A comparative biology of microglia across species. Front Cell Dev Biol. 2021;9:652748. https:\/\/doi.org\/10.3389\/fcell.2021.652748","journal-title":"Front Cell Dev Biol"},{"key":"3160_CR123","doi-asserted-by":"publisher","first-page":"eaal3222","DOI":"10.1126\/science.aal3222","volume":"356","author":"D Gosselin","year":"2017","unstructured":"Gosselin D, Skola D, Coufal NG, Holtman IR, Schlachetzki JCM, Sajti E, et al. An environment-dependent transcriptional network specifies human microglia identity. Science. 2017;356:eaal3222. https:\/\/doi.org\/10.1126\/science.aal3222","journal-title":"Science"},{"key":"3160_CR124","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","volume":"26","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Song WM, Andhey PS, Swain A, Levy T, Miller KR, et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease. Nat Med. 2020;26:131\u201342. https:\/\/doi.org\/10.1038\/s41591-019-0695-9. [published correction appears in Nat Med. 2020 Jun;26(6):981]","journal-title":"Nat Med"},{"key":"3160_CR125","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3978\/j.issn.2305-5839.2015.01.19","volume":"3","author":"XC Zhu","year":"2015","unstructured":"Zhu XC, Tan L, Wang HF, Jiang T, Cao L, Wang C, et al. Rate of early onset Alzheimer\u2019s disease: a systematic review and meta-analysis. Ann Transl Med. 2015;3:38. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2015.01.19. [published correction appears in Ann Transl Med. 2016 May;4(9):E4]","journal-title":"Ann Transl Med"},{"key":"3160_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104363","volume":"147","author":"S Commins","year":"2019","unstructured":"Commins S, Kirby BP. The complexities of behavioural assessment in neurodegenerative disorders: a focus on Alzheimer\u2019s disease. Pharmacol Res. 2019;147:104363. https:\/\/doi.org\/10.1016\/j.phrs.2019.104363","journal-title":"Pharmacol Res"},{"key":"3160_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105246","volume":"152","author":"D Cozachenco","year":"2023","unstructured":"Cozachenco D, Zimmer ER, Lourenco MV. Emerging concepts towards a translational framework in Alzheimer\u2019s disease. Neurosci Biobehav Rev. 2023;152:105246. https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105246","journal-title":"Neurosci Biobehav Rev"},{"key":"3160_CR128","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/brain\/aww017","volume":"139","author":"L Hamelin","year":"2016","unstructured":"Hamelin L, Lagarde J, Doroth\u00e9e G, Leroy C, Labit M, Comley RA, et al. Early and protective microglial activation in Alzheimer\u2019s disease: a prospective study using 18F-DPA-714 PET imaging. Brain. 2016;139:1252\u201364. https:\/\/doi.org\/10.1093\/brain\/aww017","journal-title":"Brain"},{"key":"3160_CR129","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neurobiolaging.2017.08.009","volume":"59","author":"M Vanhoutte","year":"2017","unstructured":"Vanhoutte M, Semah F, Rollin Sillaire A, Jaillard A, Petyt G, Kuchcinski G, et al. 18F-FDG PET hypometabolism patterns reflect clinical heterogeneity in sporadic forms of early-onset Alzheimer\u2019s disease. Neurobiol Aging. 2017;59:184\u201396. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.08.009","journal-title":"Neurobiol Aging"},{"key":"3160_CR130","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/0969-8051(94)90022-1","volume":"21","author":"F Shah","year":"1994","unstructured":"Shah F, Hume SP, Pike VW, Ashworth S, McDermott J. Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. Nucl Med Biol. 1994;21:573\u201381. https:\/\/doi.org\/10.1016\/0969-8051(94)90022-1","journal-title":"Nucl Med Biol"},{"key":"3160_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/2191-219X-2-15","volume":"2","author":"A Ju\u010daite","year":"2012","unstructured":"Ju\u010daite A, Csel\u00e9nyi Z, Arvidsson A, Ahlberg G, Julin P, Varn\u00e4s K, et al. Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects. EJNMMI Res. 2012;2:15. https:\/\/doi.org\/10.1186\/2191-219X-2-15","journal-title":"EJNMMI Res"},{"key":"3160_CR132","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00259-021-05425-w","volume":"49","author":"F Chauveau","year":"2021","unstructured":"Chauveau F, Becker G, Boutin H. Have (R)-[11C]PK11195 challengers fulfilled the promise? A scoping review of clinical TSPO PET studies. Eur J Nucl Med Mol Imaging. 2021;49:201\u201320. https:\/\/doi.org\/10.1007\/s00259-021-05425-w","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3160_CR133","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/life11060484","volume":"11","author":"FJ Vettermann","year":"2021","unstructured":"Vettermann FJ, Harris S, Schmitt J, Unterrainer M, Lindner S, Rauchmann BS, et al. Impact of TSPO receptor polymorphism on [18F]GE-180 binding in healthy brain and pseudo-reference regions of neurooncological and neurodegenerative disorders. Life (Basel). 2021;11:484. https:\/\/doi.org\/10.3390\/life11060484","journal-title":"Life (Basel)"},{"key":"3160_CR134","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1007\/s00259-020-04885-w","volume":"47","author":"NL Albert","year":"2020","unstructured":"Albert NL, Unterrainer M, Kaiser L, Brendel M, Vettermann FJ, Holzgreve A, et al. In response to: anatomy of 18F-GE180, a failed radioligand for the TSPO protein. Eur J Nucl Med Mol Imaging. 2020;47:2237\u201341. https:\/\/doi.org\/10.1007\/s00259-020-04885-w","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3160_CR135","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00259-019-4268-4","volume":"46","author":"P Zanotti-Fregonara","year":"2019","unstructured":"Zanotti-Fregonara P, Veronese M, Pascual B, Rostomily RC, Turkheimer F, Masdeu JC. The validity of 18F-GE180 as a TSPO imaging agent. Eur J Nucl Med Mol Imaging. 2019;46:1205\u20137. https:\/\/doi.org\/10.1007\/s00259-019-4268-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3160_CR136","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1007\/s00259-020-04732-y","volume":"47","author":"P Zanotti-Fregonara","year":"2020","unstructured":"Zanotti-Fregonara P, Pascual B, Rostomily RC, Rizzo G, Veronese M, Masdeu JC, et al. Anatomy of 18F-GE180, a failed radioligand for the TSPO protein. Eur J Nucl Med Mol Imaging. 2020;47:2233\u20136. https:\/\/doi.org\/10.1007\/s00259-020-04732-y","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3160_CR137","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1007\/s00259-019-04294-8","volume":"46","author":"NL Albert","year":"2019","unstructured":"Albert NL, Unterrainer M, Brendel M, Kaiser L, Zweckstetter M, Cumming P, et al. In response to: The validity of 18F-GE180 as a TSPO imaging agent. Eur J Nucl Med Mol Imaging. 2019;46:1208\u201311. https:\/\/doi.org\/10.1007\/s00259-019-04294-8","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3160_CR138","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abm8302","volume":"14","author":"ER Zimmer","year":"2022","unstructured":"Zimmer ER, Pascoal TA, Rosa-Neto P, Nordberg A, Pellerin L. Comment on \u201cMicroglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases\u201d. Sci Transl Med. 2022;14:eabm8302 https:\/\/doi.org\/10.1126\/scitranslmed.abm8302","journal-title":"Sci Transl Med"},{"key":"3160_CR139","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/brv.12797","volume":"97","author":"M Augusto-Oliveira","year":"2022","unstructured":"Augusto-Oliveira M, Arrifano GP, Delage CI, Tremblay M\u00c8, Crespo-Lopez ME, Verkhratsky A. Plasticity of microglia. Biol Rev Camb Philos Soc. 2022;97:217\u201350. https:\/\/doi.org\/10.1111\/brv.12797","journal-title":"Biol Rev Camb Philos Soc"},{"key":"3160_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD Sr, Jagust WJ, et al. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 2015;11:1\u201315.e154. https:\/\/doi.org\/10.1016\/j.jalz.2014.07.003","journal-title":"Alzheimers Dement"},{"key":"3160_CR141","doi-asserted-by":"publisher","first-page":"e12454","DOI":"10.1002\/dad2.12454","volume":"15","author":"VL Villemagne","year":"2023","unstructured":"Villemagne VL, Leuzy A, Bohorquez SS, Bullich S, Shimada H, Rowe CC, et al. CenTauR: toward a universal scale and masks for standardizing tau imaging studies. Alzheimers Dement (Amst). 2023;15:e12454 https:\/\/doi.org\/10.1002\/dad2.12454","journal-title":"Alzheimers Dement (Amst)"},{"key":"3160_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-022-00929-4","volume":"12","author":"JM Coughlin","year":"2022","unstructured":"Coughlin JM, Du Y, Lesniak WG, Harrington CK, Brosnan MK, O\u2019Toole R, et al. First-in-human use of 11C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor. EJNMMI Res. 2022;12:64. https:\/\/doi.org\/10.1186\/s13550-022-00929-4","journal-title":"EJNMMI Res"},{"key":"3160_CR143","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2967\/jnumed.120.244400","volume":"62","author":"R Harada","year":"2021","unstructured":"Harada R, Hayakawa Y, Ezura M, Lerdsirisuk P, Du Y, Ishikawa Y, et al. 18F-SMBT-1: a selective and reversible PET tracer for monoamine Oxidase-B imaging. J Nucl Med. 2021;62:253\u20138. https:\/\/doi.org\/10.2967\/jnumed.120.244400","journal-title":"J Nucl Med"},{"key":"3160_CR144","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.2967\/jnumed.115.168732","volume":"57","author":"E Rodriguez-Vieitez","year":"2016","unstructured":"Rodriguez-Vieitez E, Carter SF, Chiotis K, Saint-Aubert L, Leuzy A, Sch\u00f6ll M, et al. Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh compound B PET for assessing brain perfusion in Alzheimer disease. J Nucl Med. 2016;57:1071\u20137. https:\/\/doi.org\/10.2967\/jnumed.115.168732","journal-title":"J Nucl Med"},{"key":"3160_CR145","doi-asserted-by":"publisher","first-page":"5833","DOI":"10.1038\/s41380-021-01101-5","volume":"26","author":"A Kumar","year":"2021","unstructured":"Kumar A, Koistinen NA, Malarte ML, Nennesmo I, Ingelsson M, Ghetti B, et al. Astroglial tracer BU99008 detects multiple binding sites in Alzheimer\u2019s disease brain. Mol Psychiatry. 2021;26:5833\u201347. https:\/\/doi.org\/10.1038\/s41380-021-01101-5","journal-title":"Mol Psychiatry"},{"key":"3160_CR146","doi-asserted-by":"publisher","unstructured":"Mosconi L Glucose metabolism in normal aging and Alzheimer\u2019s disease: Methodological and physiological considerations for PET studies. Clin Transl Imaging 2013; 1:https:\/\/doi.org\/10.1007\/s40336-013-0026-y","DOI":"10.1007\/s40336-013-0026-y"},{"key":"3160_CR147","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s00259-018-4039-7","volume":"45","author":"J Arbizu","year":"2018","unstructured":"Arbizu J, Festari C, Altomare D, Walker Z, Bouwman F, Rivolta J, et al. Clinical utility of FDG-PET for the clinical diagnosis in MCI. Eur J Nucl Med Mol Imaging. 2018;45:1497\u2013508. https:\/\/doi.org\/10.1007\/s00259-018-4039-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3160_CR148","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1212\/WNL.0000000000201389","volume":"100","author":"S Shimohama","year":"2023","unstructured":"Shimohama S, Tezuka T, Takahata K, Bun S, Tabuchi H, Seki M, et al. Impact of amyloid and tau PET on changes in diagnosis and patient management. Neurology. 2023;100:e264\u20134. https:\/\/doi.org\/10.1212\/WNL.0000000000201389","journal-title":"Neurology"},{"key":"3160_CR149","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1093\/brain\/awad042","volume":"146","author":"CR Jack","year":"2023","unstructured":"Jack CR, Wiste HJ, Algeciras-Schimnich A, Figdore DJ, Schwarz CG, Lowe VJ, et al. Predicting amyloid PET and tau PET stages with plasma biomarkers. Brain. 2023;146:2029\u201344. https:\/\/doi.org\/10.1093\/brain\/awad042","journal-title":"Brain"},{"key":"3160_CR150","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","volume":"28","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele R, Pichet Binette A, Groot C, Smith R, Strandberg O, Palmqvist S, et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat Med. 2022;28:2381\u20137. https:\/\/doi.org\/10.1038\/s41591-022-02049-x","journal-title":"Nat Med"},{"key":"3160_CR151","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nrneurol.2017.17","volume":"13","author":"C Ridler","year":"2017","unstructured":"Ridler C. Neuroimmunology: Microglia-induced reactive astrocytes - toxic players in neurological disease? Nat Rev Neurol. 2017;13:127 https:\/\/doi.org\/10.1038\/nrneurol.2017.17","journal-title":"Nat Rev Neurol"},{"key":"3160_CR152","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther. 2023;8:359 https:\/\/doi.org\/10.1038\/s41392-023-01588-0","journal-title":"Signal Transduct Target Ther"},{"key":"3160_CR153","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.it.2020.07.006","volume":"41","author":"SA Liddelow","year":"2020","unstructured":"Liddelow SA, Marsh SE, Stevens B. Microglia and astrocytes in disease: dynamic duo or partners in crime? Trends Immunol. 2020;41:820\u201335. https:\/\/doi.org\/10.1016\/j.it.2020.07.006","journal-title":"Trends Immunol"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03160-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03160-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03160-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:06:15Z","timestamp":1765537575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-03160-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":153,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["3160"],"URL":"https:\/\/doi.org\/10.1038\/s41380-025-03160-4","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HZ has served at scientific advisory boards and\/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Alzecure, Biogen, Cellectricon, Fujirebio, Lilly, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). KB has served as a consultant and at advisory boards for Acumen, ALZPath, AriBio, BioArctic, Biogen, Eisai, Lilly, Moleac Pte. Ltd, Novartis, Ono Pharma, Prothena, Roche Diagnostics, and Siemens Healthineers; has served at data monitoring committees for Julius Clinical and Novartis; has given lectures, produced educational materials and participated in educational programs for AC Immune, Biogen, Celdara Medical, Eisai, and Roche Diagnostics; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, outside the work presented in this paper. AS-P reports on a material transfer agreement with Ionis Pharmaceuticals, Inc. PRN has served on the scientific advisory board of Novonordisk, Eisai, and Ely Lilly. He has also served as a consultant to Eisai, and Cerveau radiopharmaceuticals. ERZ has served on the scientific advisory board,\u00a0as a consultant or speaker for Nintx, Novo Nordisk, Biogen, Lilly and Magdalena Biosciences. He is also a co-founder and a minority shareholder at masima. Other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}